After a fruitful year of introducing our cloud-based high performance genomics solutions in the United States and Canada, we have established close relationships with major research and clinical labs in the region. With the opening of our new office, we are excited to demonstrate our increased commitment to service them even better.
From our Boston office our team of business developers, field application specialists and customer support professionals will be available to schedule onsite and local meetings, provide training and on-boarding sessions to our customers, and to assure a stronger presence in the community.
The office is strategically located in the heart of Boston, in a eleven story building at the 745 Atlantic Ave, Boston MA, the space is perfectly positioned in Boston’s Leather District just minutes away from the South Station Terminal.
“The United States has always been a key market for us,” says Hans Cobben, CEO of BlueBee, “This is just the first of a number of investments we will be making in 2016 to expand the resources needed to support and continue to grow our business here. We are delighted to demonstrate our increased commitment to our US customers by adding local resources to better service their needs for a global and scalable genomic data analysis platform. Our business in the United States is growing rapidly and we are committed to continue our investments in such an important market.”
BlueBee operates in globally distributed high-performance computing centers. Processing and storage of the genomics data are contractually guaranteed in the region of choice to comply with local regulatory requirements and data privacy regulations. With this unique feature global players have one single interface for managing projects and data processing across the globe without the burden of managing multiple datacenters separately, nor losing the ability to collaborate and share data. For the region BlueBee operates on 5 datacenters in the US (Dallas, Houston, San José, Seattle and Washington DC), two in Canada (Montreal and Toronto), one in Mexico and one in Brazil.